Form 4: CEL-SCI CFO Patricia Prichep Granted 12,000 Stock Options

CEL-SCI Corporation's Chief Financial Officer, Patricia B. Prichep, was granted 12,000 stock options with an exercise price of $8.20 per share, vesting over three years.

Summary

• Patricia B. Prichep, Chief Financial Officer of CEL-SCI Corp (CVM), was granted 12,000 stock options.
• The options have an exercise price of $8.20 per share.
• The grant date for these options was July 28, 2025.
• The options will vest in three equal annual installments, commencing one year after the grant date.
• The expiration date for these options is July 27, 2035.
• Following this transaction, Ms. Prichep beneficially owns 75,127 derivative securities (options).

Sentiment

Score: 6

Explanation: The grant of stock options to a key executive is generally a neutral to slightly positive event, as it aligns management incentives with shareholder interests, without indicating any immediate financial performance changes.

Positives

• The grant of stock options aligns the Chief Financial Officer's interests with those of shareholders, providing an incentive for long-term company performance.
• The options have a long expiration date (July 27, 2035), offering a significant window for potential value realization.

Future Outlook

The stock options are structured to vest over three years, indicating a long-term incentive for the Chief Financial Officer, aligning her future compensation with the company's performance over this period.

Industry Context

This is a routine executive compensation event common across publicly traded companies, particularly in the biotechnology and pharmaceutical sectors like CEL-SCI, to attract, retain, and incentivize key management personnel.

Stakeholder Impact

• Shareholders: Potential for future dilution if options are exercised, but also benefit from aligned management incentives.
• Chief Financial Officer: Receives additional equity compensation, increasing her stake and potential future wealth tied to company performance.

Next Steps

• The stock options will vest in three equal annual installments, commencing one year after the grant date of July 28, 2025.

Key Dates

Keywords

CEL-SCI Corp, CVM, stock options, executive compensation, insider transaction, Form 4, Chief Financial Officer, Patricia Prichep, equity compensation